Difficulty: Medium
Average Score: 88%
Practice
Zafirlucast prevents aspirin-sensitive asthma. This consideration is:
Correct answer
A
Rationale
Step-by-step rationale:
1. Zafirlukast is a leukotriene receptor antagonist used to treat asthma.
2. Aspirin-sensitive asthma is a condition triggered by aspirin and other NSAIDs.
3. Studies have shown that zafirlukast can prevent bronchoconstriction in aspirin-sensitive asthma.
4. Therefore, the statement that Zafirlukast prevents aspirin-sensitive asthma is TRUE.
Summary:
- Choice A is correct because zafirlukast has been proven to prevent aspirin-sensitive asthma.
- Choice B is incorrect as evidence supports the effectiveness of zafirlukast.
- Choice C is incorrect as not all choices are true.
- Choice D is incorrect as the correct answer is A, making this choice incorrect.
1. Zafirlukast is a leukotriene receptor antagonist used to treat asthma.
2. Aspirin-sensitive asthma is a condition triggered by aspirin and other NSAIDs.
3. Studies have shown that zafirlukast can prevent bronchoconstriction in aspirin-sensitive asthma.
4. Therefore, the statement that Zafirlukast prevents aspirin-sensitive asthma is TRUE.
Summary:
- Choice A is correct because zafirlukast has been proven to prevent aspirin-sensitive asthma.
- Choice B is incorrect as evidence supports the effectiveness of zafirlukast.
- Choice C is incorrect as not all choices are true.
- Choice D is incorrect as the correct answer is A, making this choice incorrect.